OMNIA

OMNIA is a European-led, globally connected research and training programme redefining how nanotherapeutics are designed and translated for hard-to-treat cancers. By integrating spatial multi-omics, advanced tumor models, and interpretable AI, OMNIA uncovers how nanoparticles interact with the tumor microenvironment—turning complex molecular data into actionable design rules for safer, more effective treatments. Through a harmonized nanoparticle platform, standardized SOPs, and FAIR-compliant data pipelines, OMNIA transforms fragmented nanomedicine studies into a reproducible, data-driven field. Its consortium of leading academic, clinical, and industrial partners from Europe, North America, and Asia bridges expertise in materials science, oncology, and AI to deliver open spatial atlases, validated analysis tools, and regulatory-ready templates. At its core, OMNIA is also a training ecosystem. Over 80 researchers will engage in structured, cross-sector secondments—“capsule curricula” that combine hands-on experimentation, AI analysis, and translational science. This approach cultivates a new generation of scientists fluent in materials–biology–AI integration and capable of driving Europe’s next wave of cancer nanomedicine. Organized into five interconnected work packages spanning nanoparticle design, characterization, spatial biology, AI, and ethics, OMNIA combines scientific excellence, industrial innovation, and mobility-driven collaboration—laying the foundation for a sustainable, spatially informed, AI-enabled future in nanomedicine.